Lv1
40 积分 2022-07-16 加入
A cost effective strategy of bevacizumab in treatment of primary ovarian cancer — A subset analysis of ICON 7 trial
1个月前
已完结
Cost-effectiveness of olaparib maintenance therapy when used with and without restriction by BRCA1/2 mutation status for platinum-sensitive relapsed ovarian cancer
1个月前
已完结
Cost-effectiveness analysis of olaparib as a maintenance monotherapy for patients with newly diagnosed advanced ovarian cancer and a BRCA1/2 mutation: A United States payer perspective
1个月前
已完结
PCN85 COST-EFFECTIVENESS OF OLAPARIB AS A MAINTENANCE TREATMENT OPTION FOR NEWLY DIAGNOSED BRCA-MUTATED OVARIAN CANCER WHO ARE IN RESPONSE AFTER FIRST-LINE PLATINUM-BASED CHEMOTHERAPY IN PANAMA
1个月前
已完结
A cost-effectiveness analysis of three PARP inhibitors for maintenance therapy in platinum-sensitive recurrent ovarian cancer
1个月前
已完结
Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE
2个月前
已完结
Treatment guidelines in ovarian cancer
2个月前
已完结
[Epithelial ovarian cancer (advanced stage): consensus conference (1998)]
2个月前
已关闭
Early detection of the Fas-FasL system in hepatic graft-versus-host disease after rat small-bowel transplantation
2个月前
已完结
皖公网安备34019202002308
